Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04746924
Title A Study of BGB-A1217 With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors BeiGene
Indications

lung non-small cell carcinoma

Therapies

Tislelizumab

BGBA1217 + Tislelizumab

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST